Thus, FoxO3a expression might not only be considered a favorable prognostic marker in breast cancer, as described elsewhere [24,46] but, even more importantly, it might also be predictive of the potential efficacy of the antiestrogen therapy. Here, FOXO3 is linked to breast cancer.